Evotec AG and Harvard University Expand Strategic Alliance Into Kidney Disease

HAMBURG, Germany, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced a second strategic alliance with Harvard University, this time including Brigham and Women's Hospital aimed at discovering and developing new biomarkers and treatments in the field of kidney disease. The first successful collaboration "CureBeta" was established in March 2011 to develop new diabetes therapies targeting beta cell regeneration.

Back to news